Chartwell Rx Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?
CHARTWELL RX has one hundred and sixty-one approved drugs.
Drugs and US Patents for Chartwell Rx
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040196-006 | Sep 30, 1997 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Chartwell Rx | REPAGLINIDE | repaglinide | TABLET;ORAL | 078555-002 | Jan 22, 2014 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Chartwell Rx | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 087918-001 | Dec 22, 1983 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Chartwell Rx | SPIRONOLACTONE | spironolactone | TABLET;ORAL | 086809-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Chartwell Rx | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040196-009 | Jul 26, 2000 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Chartwell Rx | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089837-001 | Aug 18, 1988 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.